Endotoxin release and cytokine production in acute and chronic meningococcaemia

Clinical and Experimental Immunology

Volumn 114, Issue 2, 1998, Pages 215-219

  Prins, J M ^a   Lauw, F N ^a   Derkx, B H F ^a   Speelman, P ^a   Kuijper, E J ^a   Dankert, J ^a   Van Deventer, S J H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Chronic meningococcaemia; Cytokines; Endotoxin; Meningococci; Sepsis

Indexed keywords

CYTOKINE; ENDOTOXIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN TISSUE; INFANT; MENINGOCOCCEMIA; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; SEPTIC SHOCK;

ADOLESCENT; BACTEREMIA; CHILD; CHILD, PRESCHOOL; ENDOTOXINS; HUMANS; INFANT; INTERLEUKIN-6; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031790051     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00715.x     Document Type: Article

References (22)

1. Apicella MA. Neisseria meningitidis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 4th edn. New York: Churchill Livingstone 1995:1896-909.
2. Verheul AFM, Snippe H, Poolman JT. Meningococcal lipopolysaccharides: virulence factor and potential vaccine component. Microbiol Rev 1993; 57:34-49.
3. Benoit FL. Chronic meningococcemia. Case report and review of the literature. Am J Med 1963; 35:103-12.
4. Dock W. Intermittent fever of seven months' duration due to meningococcemia (with an analysis of sixty-eight reported cases of meningococcemia). JAMA 1924; 83:31-33.
5. Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, Sørensen E. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989; 159:195-204.
6. Dunn KLR, Virji M, Moxon ER. Investigations into the molecular basis of meningococcal toxicity for human endothelial and epithelial cells: the synergistic effect of LPS and pili. Microb Pathogen 1995; 18:81-96.
7. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med 1989; 169:333-8.
8. Van Deuren M, van der Ven-Jongekrijg J, Bartelink AKM, van Dalen R, Sauerwein RW, van der Meer JWM. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis 1995; 172:433-4.
9. Derkx B, Marchant A, Goldman M, Bijlmer R, van Deventer S. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J Infect Dis 1995; 171:229-32.
10. Derkx HHF, van den Hock J, Redekop WK, Bijlmer RPGM, van Deventer SJH, Bossuyt PMM. Meningococcal disease: a comparison of eight seventy scores in 125 children. Intens Care Med 1996; 22:1433-41.
11. Balows A, Hausler WJ Jr, Herrmann KL, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology, 5th edn. Washington: American Society for Microbiology, 1991.
12. Prins JM, Speelman P, Kuijper EJ, Danken J, van Deventer SJH. No increase in endotoxin release during antibiotic killing of meningococci. J Antimicrob Chemother 1997; 39:13-18.
13. Zangwill KM, Stout RW, Carlone GM et al. Duration of antibody response alter meningococcal polysaccharide vaccination in US Air Force personnel. J Infect Dis 1994; 169:847-52.
14. Fasano MB, Sullivan KE, Ibsen L, Winkelstein JA. Chronic meningococcemia in a child with a deficiency of the sixth component of complement. Pediatr Allergy Immunol 1993; 4:214-6.
15. Nielsen HE, Koch C, Mansa B, Magmissen P, Bergmann OJ. Complement and immunoglobulin studies in 15 cases of chronic meningococcemia: properdin deficiency and hypoimmunoglobulinemia. Scand J Infect Dis 1990; 22:31-36.
16. Spanjaard L, Bol P, Zanen HC. Chronische meningokokkensepsis, een vergeten ziekte. Ned Tijdschr Geneesk 1985; 129:352-5.
17. Andersen BM, Solberg O. Effect of benzylpenicillin in mice infected with endotoxin-liberating or non-liberating variant strains of Neisseria meningitidis. Scand J Infect Dis 1984; 16:257-66.
18. Andersen BM, Solberg O. Endotoxin liberation and invasivity of Neisseria meningitidis. Scand J Infect Dis 1984; 16:247-54.
19. Andersen BM, Solberg O, Bryn K, Frøholm LO, Gaustad P, Hoiby EA, Kristiansen BE, Bøvre K. Endotoxin liberation from Neisseria meningitidis isolated from carriers and clinical cases. Scand J Infect Dis 1987; 19:409-19.
20. Mellado MC, Rodríguez-Contreras R, Fernandez-Crehuet M. Lopez-Gigosos R, Delgado Rodríguez M, Galvez-Vargas R. Endotoxin liberation by strains of N. meningitindis isolated from patients and healthy carriers. Epidemiol Infect 1991; 106:289-95.
21. Jones DM, Borrow R, Fox AJ, Gray S, Cartwright KA, Poolman JT. The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis. Microb Pathogen 1992; 13:219-24.
22. Bruin KF, von der Möhlen MAM, Derkx BHF, Jansen J, ten Cate JW, van Deventer SJH. Characterization of the endotoxin-induced TNF release in whole blood and peripheral blood mononuclcar cells. In: Bruin KF. Endotoxin responsiveness in humans. PhD Thesis, University of Amsterdam 1994:31-42.